Newly Arrival Antibiotics 10% Injection Oxytetracycline - Eyedrops of Gentamycin sulfate – KeMing Medicines Detail:
| FOB Price | Inquiry |
| Min.Order Quantity | 50000 bottles |
| Supply Ability | 20,000,000 bottles/Month |
| Port | Shanghai |
| Payment Terms | T/T in advance |
| Product Detail | |
| Product name | Eyedrops of Gentamycin sulfate |
| Specification | 0.4%10ml |
| Description | A clear, colourless liquid |
| Standard | BP |
| Package | 1bottle/box |
| Transportation | Ocean,Land,Air |
| Certificate | GMP |
| Price | Inquiry |
| Quality guaranteeperiod | for 36 months |
| Product Description | [Indications] For the topical treatment of infections of the external eye and ear caused by susceptible bacteria.Such infections include conjunctivitis,keratitis and keratoconjunctivitis,corneal ulcers,blepharaitis and blepharonoconjunctivitis,acute melbomiantis,、and dacryocustitis. [Dosage and administration]Trasient one or two drops into the affected eye/ear every four hours.In severe infections,dosage may be increased to as much as two drops once every hour. |
Product detail pictures:
Related Product Guide:
Drugs, Vitamins, Pills, Pills, Pills
Disease, Doctors, Drugs and Vitamins!
The pretty loaded projects management experiences and one to a person support model make the high importance of business enterprise communication and our easy understanding of your expectations for Newly Arrival Antibiotics 10% Injection Oxytetracycline - Eyedrops of Gentamycin sulfate – KeMing Medicines, The product will supply to all over the world, such as: Gabon, San Francisco, Johannesburg, Whether selecting a current product from our catalog or seeking engineering assistance for your application, you can talk to our customer service center about your sourcing requirements. We can provided good quality with competitive price for you.
By David from Russia - 2017.09.16 13:44
This enterprise in the industry is strong and competitive, advancing with the times and develop sustainable, we are very pleased to have a opportunity to cooperate!
By Christopher Mabey from Puerto Rico - 2018.06.21 17:11
